Cargando…

Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region

OBJECTIVES: Value of chest CT was mainly studied in area of high COVID-19 incidence. The aim of this study was therefore to evaluate chest CT performances to diagnose COVID-19 pneumonia with regard to RT-PCR as reference standard in a low incidence area. METHODS: A survey was sent to radiology depar...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Clément, Naudin, Mathieu, Tasu, Jean-Pierre, Leclerc, Charles, Depaire, Lucas, Subervillle, Marie, Vionnet, Mathilde, Guillevin, Rémy, Herpe, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054502/
https://www.ncbi.nlm.nih.gov/pubmed/33871709
http://dx.doi.org/10.1007/s00330-021-07863-4
_version_ 1783680302789427200
author Thomas, Clément
Naudin, Mathieu
Tasu, Jean-Pierre
Leclerc, Charles
Depaire, Lucas
Subervillle, Marie
Vionnet, Mathilde
Guillevin, Rémy
Herpe, Guillaume
author_facet Thomas, Clément
Naudin, Mathieu
Tasu, Jean-Pierre
Leclerc, Charles
Depaire, Lucas
Subervillle, Marie
Vionnet, Mathilde
Guillevin, Rémy
Herpe, Guillaume
author_sort Thomas, Clément
collection PubMed
description OBJECTIVES: Value of chest CT was mainly studied in area of high COVID-19 incidence. The aim of this study was therefore to evaluate chest CT performances to diagnose COVID-19 pneumonia with regard to RT-PCR as reference standard in a low incidence area. METHODS: A survey was sent to radiology department in 4 hospitals in an administrative French region of weak disease prevalence (3.4%). Study design was approved by the local institutional review board and recorded on the clinicaltrial.gov website (NCT04339686). Written informed consent was waived due to retrospective anonymized data collection. Patients who underwent a RT-PCR and a chest CT scan within 48 h for COVID-19 pneumonia suspicion were consecutively included. Diagnostic accuracy including the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of chest CT regarding RT-PCR as reference standard were calculated. RESULTS: One hundred twenty-nine patients had abnormal chest CT findings compatible with a COVID-19 pneumonia (26%, 129/487). Among the 358 negative chest CT findings, 3% (10/358) were RT-PCR positive. Chest CT sensitivity, specificity, positive, and negative predictive value were respectively 87% (IC95: 85, 89; 69/79), 85% (IC95: 83, 87; 348/408), 53% (IC95: 50, 56; 69/129), and 97% (IC95: 95, 99; 348/358). CONCLUSIONS: In a low prevalence area, chest CT scan is a good diagnostic tool to rule out COVID-19 infection among symptomatic suspected patients. KEY POINTS: • In a low prevalence area (3.4% in the administrative area and 5.8% at mean in the study) chest CT sensitivity and specificity for diagnosing COVID-19 pneumonia were 87% and 85% respectively. • In patients with negative chest CT for COVID-19 pneumonia, the negative predictive value of COVID-19 infection was 97% (348/358 subjects). • Performance of CT was equivalent between the 4 centers participating to this study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-07863-4.
format Online
Article
Text
id pubmed-8054502
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-80545022021-04-19 Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region Thomas, Clément Naudin, Mathieu Tasu, Jean-Pierre Leclerc, Charles Depaire, Lucas Subervillle, Marie Vionnet, Mathilde Guillevin, Rémy Herpe, Guillaume Eur Radiol Chest OBJECTIVES: Value of chest CT was mainly studied in area of high COVID-19 incidence. The aim of this study was therefore to evaluate chest CT performances to diagnose COVID-19 pneumonia with regard to RT-PCR as reference standard in a low incidence area. METHODS: A survey was sent to radiology department in 4 hospitals in an administrative French region of weak disease prevalence (3.4%). Study design was approved by the local institutional review board and recorded on the clinicaltrial.gov website (NCT04339686). Written informed consent was waived due to retrospective anonymized data collection. Patients who underwent a RT-PCR and a chest CT scan within 48 h for COVID-19 pneumonia suspicion were consecutively included. Diagnostic accuracy including the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of chest CT regarding RT-PCR as reference standard were calculated. RESULTS: One hundred twenty-nine patients had abnormal chest CT findings compatible with a COVID-19 pneumonia (26%, 129/487). Among the 358 negative chest CT findings, 3% (10/358) were RT-PCR positive. Chest CT sensitivity, specificity, positive, and negative predictive value were respectively 87% (IC95: 85, 89; 69/79), 85% (IC95: 83, 87; 348/408), 53% (IC95: 50, 56; 69/129), and 97% (IC95: 95, 99; 348/358). CONCLUSIONS: In a low prevalence area, chest CT scan is a good diagnostic tool to rule out COVID-19 infection among symptomatic suspected patients. KEY POINTS: • In a low prevalence area (3.4% in the administrative area and 5.8% at mean in the study) chest CT sensitivity and specificity for diagnosing COVID-19 pneumonia were 87% and 85% respectively. • In patients with negative chest CT for COVID-19 pneumonia, the negative predictive value of COVID-19 infection was 97% (348/358 subjects). • Performance of CT was equivalent between the 4 centers participating to this study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-07863-4. Springer Berlin Heidelberg 2021-04-19 2021 /pmc/articles/PMC8054502/ /pubmed/33871709 http://dx.doi.org/10.1007/s00330-021-07863-4 Text en © European Society of Radiology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Chest
Thomas, Clément
Naudin, Mathieu
Tasu, Jean-Pierre
Leclerc, Charles
Depaire, Lucas
Subervillle, Marie
Vionnet, Mathilde
Guillevin, Rémy
Herpe, Guillaume
Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region
title Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region
title_full Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region
title_fullStr Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region
title_full_unstemmed Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region
title_short Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region
title_sort efficacy of chest ct scan for covid-19 diagnosis in a low prevalence and incidence region
topic Chest
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054502/
https://www.ncbi.nlm.nih.gov/pubmed/33871709
http://dx.doi.org/10.1007/s00330-021-07863-4
work_keys_str_mv AT thomasclement efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT naudinmathieu efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT tasujeanpierre efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT leclerccharles efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT depairelucas efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT subervilllemarie efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT vionnetmathilde efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT guillevinremy efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion
AT herpeguillaume efficacyofchestctscanforcovid19diagnosisinalowprevalenceandincidenceregion